Paul B Manning - Director at Candel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
CADL on Nasdaq
All Insider Reports
All Insider Reports

Paul B Manning - trading volume in the past year for Candel Therapeutics, Inc.

Holdings reported by Paul B Manning for Candel Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,763,527 $15,061,222 $5.45 23 Feb 2026 By Paul B. Manning Revocable Trust
Common Stock 1,681,000 $10,254,100 $6.10 23 Feb 2026 Direct
Common Stock 1,303,752 $7,952,887 $6.10 23 Feb 2026 By BKB Growth Investments, LLC
Stock Option (Right to Buy) 14,240 17 Jun 2025 Direct Common Stock

Transactions reported by Paul B Manning for Candel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.